Inventor · disambiguated record
Wei-Wei Chang
Also filed as: CHANG WEI-WEI
10 granted patents·3 pending applications·79 citations·filing 2007–2021
87Inventor score
Top patents by PatentIndex Score
13 records- 0194US8846039B2Method for ameliorating pruritusCHUNG YIH-LIN·Filed 2007·Granted Sep 30, 2014·49 cites·15 claims
- 0287US10098895B2Treatment of symptoms related to neurodegenerative disorders through pharmacological dermal activation of cranial nervesGLIA LLC·Filed 2017·Granted Oct 16, 2018·10 cites·16 claims
- 0387US8163764B2Skincare methodsCHUNG YIH-LIN·Filed 2010·Granted Apr 24, 2012·8 cites·18 claims
- 0486US8492438B2Treatment skin disordersCHUNG YIH-LIN·Filed 2011·Granted Jul 23, 2013·6 cites·19 claims
- 0573US9895343B2Method for treating tumors with cannabinoidsGLIA LLC·Filed 2016·Granted Feb 20, 2018·1 cites·8 claims
- 0671US8163731B2Method and dosage regimens for eliminating a chemical substance in bloodSLATER KENNETH C·Filed 2008·Granted Apr 24, 2012·3 cites·12 claims
- 0768US9682032B2Cranial delivery of pharmaceuticalsGLIA LLC·Filed 2014·Granted Jun 20, 2017·1 cites·2 claims
- 0861US9211268B2Method and dosage regimens for eliminating a chemical substance in bloodSLATER KENNETH C·Filed 2012·Granted Dec 15, 2015·1 cites·9 claims
- 0951US10251835B2Cranial delivery of pharmaceuticalsGLIA LLC·Filed 2017·Granted Apr 9, 2019·0 cites·9 claims
- 1051US2022401458A1Testosterone compositionsGLIA LLC·Filed 2020·Application pending·0 cites
- 1150US9925201B2Compositions and treatment for eye diseases and disordersGLIA LLC·Filed 2016·Granted Mar 27, 2018·0 cites·14 claims
- 1248US2015216877A1Compositions and treatment for eye diseases and disordersRHODES TECHNOLOGIES·Filed 2013·Application pending·0 cites
- 1344US2023091716A1Progesterone CombinationsGLIA LLC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Wei-Wei Chang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →